Community-based screening of hepatitis C with a one-step RNA detection algorithm from dried-blood spots: Analysis of

V Saludes1,2, C Folch2,3, A Morales-Carmona4

  • 1Microbiology Service, Germans Trias i Pujol University Hospital, Germans Trias i Pujol Health Sciences Research Institute (IGTP), Badalona, Spain.

Insights

A new one-step strategy using dried blood spot testing for hepatitis C virus (HCV) RNA in at-risk populations showed good performance but did not detect silent infections. Continued monitoring is recommended.

Area of Science:

  • Infectious Diseases
  • Hepatology
  • Public Health

Background:

  • Silent hepatitis C virus (HCV) infections pose a diagnostic challenge in key populations.
  • Limited bio-behavioral data exists for HIV-negative men who have sex with men (MSM) and sex workers regarding HCV.
  • Alternative diagnostic strategies are needed for these at-risk groups.

Purpose of the Study:

  • To describe and evaluate a community-based, one-step HCV screening and confirmation strategy.
  • To assess HCV prevalence and collect bio-behavioral data in HIV-negative MSM and sex workers in Barcelona.
  • To determine the benefits of a real-time RT-PCR assay for HCV-RNA in dried blood spots (DBS).

Main Methods:

  • Validated a real-time RT-PCR assay for HCV-RNA detection in DBS.
  • Implemented DBS testing alongside an antibody point-of-care test in a community setting.
  • Collected HCV prevalence and bio-behavioral data from 580 participants.

Main Results:

  • The molecular assay demonstrated high precision, reproducibility, sensitivity, and specificity.
  • HCV prevalence was 0.75% among HIV-negative MSM; no silent HCV cases were diagnosed.
  • High-risk sexual practices and drug use for sex were frequently reported, with HIV prevalence at 4.7% in MSM and 10% in sex workers.

Conclusions:

  • HCV-RNA testing in DBS performed well, but the one-step strategy showed limited benefit in this specific setting.
  • Despite no silent HCV infections detected, high-risk behaviors and STI prevalence underscore the need for ongoing monitoring.
  • Periodic behavioral surveillance, rapid antibody testing, and molecular DBS confirmation are recommended for HCV surveillance in these populations.

Related Concept Videos